GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases

被引:283
作者
Volchkov, VE [1 ]
Becker, S [1 ]
Volchkova, VA [1 ]
Ternovoj, VA [1 ]
Kotov, AN [1 ]
Netesov, SV [1 ]
Klenk, HD [1 ]
机构
[1] UNIV MARBURG,INST VIROL,D-35037 MARBURG,GERMANY
基金
俄罗斯基础研究基金会;
关键词
D O I
10.1006/viro.1995.0052
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The glycoprotein gene of Ebola virus contains a translational stop codon in the middle, thus preventing synthesis of full-length glycoprotein. Twenty percent of the mRNA isolated from Ebola virus-infected cells was shown to be edited, containing one additional nontemplate A in a stretch of seven consecutive A residues. Only the edited mRNA species encoded full-length glycoprotein, whereas the exact copies of the viral template coded for a smaller secreted glycoprotein. Expression of the glycoprotein by an in vitro transcription/translation system, by the vaccinia virus/T7 polymerase system, and by recombinant vaccinia virus revealed that full-length glycoprotein was synthesized not only when the edited glycoprotein gene (8A's) was used as a template for T7 and vaccinia virus polymerases, but also when the nonedited (genomic) glycoprotein gene was used. Analysis of mRNA produced by T7 and vaccinia virus polymerase from the 7A's construct revealed that 1-5% contained alterations at the same site that was also edited by the Ebola virus polymerase. Our data indicate that the editing site in the Ebola virus glycoprotein gene is recognized not only by Ebola virus polymerase but also by DNA-dependent RNA polymerases of different origin. (C) 1995 Academic Press, Inc.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 46 条
  • [1] BOWEN ETW, 1977, LANCET, V1, P571
  • [2] MEASLES-VIRUS EDITING PROVIDES AN ADDITIONAL CYSTEINE-RICH PROTEIN
    CATTANEO, R
    KAELIN, K
    BACZKO, K
    BILLETER, MA
    [J]. CELL, 1989, 56 (05) : 759 - 764
  • [3] VACCINIA VIRUS EXPRESSION VECTOR - COEXPRESSION OF BETA-GALACTOSIDASE PROVIDES VISUAL SCREENING OF RECOMBINANT VIRUS PLAQUES
    CHAKRABARTI, S
    BRECHLING, K
    MOSS, B
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) : 3403 - 3409
  • [4] CHEPURNOV AA, 1994, PROB VIROL, V6, P254
  • [5] INHIBITION OF LYMPHOCYTE-PROLIFERATION BY A SYNTHETIC PEPTIDE HOMOLOGOUS TO RETROVIRAL ENVELOPE PROTEINS
    CIANCIOLO, GJ
    COPELAND, TD
    OROSZLAN, S
    SNYDERMAN, R
    [J]. SCIENCE, 1985, 230 (4724) : 453 - 455
  • [6] DESCRIPTIVE ANALYSIS OF EBOLA VIRUS PROTEINS
    ELLIOTT, LH
    KILEY, MP
    MCCORMICK, JB
    [J]. VIROLOGY, 1985, 147 (01) : 169 - 176
  • [7] GLYCOSYLATION AND OLIGOMERIZATION OF THE SPIKE PROTEIN OF MARBURG VIRUS
    FELDMANN, H
    WILL, C
    SCHIKORE, M
    SLENCZKA, W
    KLENK, HD
    [J]. VIROLOGY, 1991, 182 (01) : 353 - 356
  • [8] Feldmann H, 1993, Arch Virol Suppl, V7, P81
  • [9] LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE
    FELGNER, PL
    GADEK, TR
    HOLM, M
    ROMAN, R
    CHAN, HW
    WENZ, M
    NORTHROP, JP
    RINGOLD, GM
    DANIELSEN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7413 - 7417
  • [10] EUKARYOTIC TRANSIENT-EXPRESSION SYSTEM BASED ON RECOMBINANT VACCINIA VIRUS THAT SYNTHESIZES BACTERIOPHAGE-T7 RNA-POLYMERASE
    FUERST, TR
    NILES, EG
    STUDIER, FW
    MOSS, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) : 8122 - 8126